1. Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev 2022; 43: 678-719.
2.
Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104: 393-406.
3.
Stewart EA. Uterine fibroids. Lancet 2001; 357: 293-8.
4.
Volkers NA, Hehenkamp WJ, Birnie E, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 2007; 196: 519.e1-11.
5.
Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007; 356: 360-70.
6.
Hehenkamp WJ, Volkers NA, Donderwinkel PF, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 2005; 193: 1618-29.
7.
Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31: 73-85.
8.
Moss JG, Cooper KG, Khaund A, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 2011; 118: 936-44.
9.
Wu X, Yin B, Qiu G. Study on the effect of super selective uterine artery embolization in the treatment of cesarean scar pregnancy. Modern Diagn Treat 2017; 28: 992-4.
10.
Cook DA, Reed DA. Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med 2015; 90: 1067-76.
11.
Cao X, He G. Effect of uterine artery embolization on ovarian function in patients with hysteromyoma. Shan Dong Yi Yao 2018; 58: 76-8.
12.
Feng B, Wang X, Zhai J, et al. The influence on ovarian function after hysterectomy or uterine artery embolization. Zhong Guo Sheng Yu Jian Kang Za Zhi 2007; 18: 340-3.
13.
Guan B, Zhang F, Zhong P, et al. Influence of hysterectomy and uterine artery embolization on ovarian function in patients with uterine fibroids. China Prac Med 2018; 13: 32-4.
14.
Liu F, Hu J, Qin J, et al. Effect of uterine artery embolization and hysterectomy on ovarian function in patients with hysteromyoma. He Bei Yi Yao 2014; 17: 2663-4.
15.
Luo H, Zhang Y. Effect of uterine artery embolization and hysterectomy on ovarian function in patients with uterine myoma. J Chin Oncol 2014; 20: 432-4.
16.
Yang D. Effect of uterine artery embolization on ovarian function in patients with uterine myoma. Zhong Wai Yi Xue Yan Jiu 2017; 15: 32-4.
17.
Zhou Y, Wang S, Yan C, et al. Effect and safety of uterine artery embolization for patients with symptomatic uterine myoma. J Bethune Med Sci 2018; 16: 464-6.
18.
Chen ZY, Jin HM, Shi HY. Clinical efficacy of Gengxueting and its effect on estrogen receptor and progesterone receptor in patients with hysteromyoma. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 219-21.
19.
Li A, Wang Y, Dong W, et al. Inhibitory effect on estrogen production and its influence on invasive ability of human endometrial cells of endometriosis by medicated serum of SLW. Zhongguo Zhong Yao Za Zhi 2010; 35: 1607-11.
20.
Li A, Wang Y, Xu XY. Inhibitory effect of Jiawei Sanleng pill medicated serum on estrogen production and its influence on apoptosis of human endometrial cells of endometriosis. Zhong Yao Cai 2010; 33: 401-6.
21.
Li A, Xu XY, Wang H, et al. Study on inhibitory effect of medicated serum of SLW on estrogen production by human endometrial cells of endometriosis. Zhongguo Zhong Yao Za Zhi 2008; 33: 686-90.
22.
Fong YF, Lim FK, Arulkumaran S. Prophylactic oophorectomy: a continuing controversy. Obstet Gynecol Surv 1998; 53: 493-9.
23.
Ravina JH, Herbreteau D, Ciraru Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-2.
24.
Czuczwar P, Stepniak A, Milart P, et al. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study. J Ovarian Res 2018; 11: 45.
25.
Hehenkamp WJ, Volkers NA, Broekmans FJ, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 2007; 22: 1996-2005.
26.
Kim CW, Shim HS, Jang H, et al. The effects of uterine artery embolization on ovarian reserve. Eur J Obstet Gynecol Reprod Biol 2016; 206: 172-6.
27.
Spies JB, Roth AR, Gonsalves SM, et al. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol 2001; 12: 437-42.
Copyright: © 2024 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
